Point-of-care testing: state-of-the art and perspectives

Abstract: Point-of-care testing (POCT) is becoming an increasingly popular way to perform laboratory tests closer to the patient. This option has several recognized advantages, such as accessibility, portability, speed, convenience, ease of use, ever-growing test panels, lower cumulative healthcare costs when used within appropriate clinical pathways, better patient empowerment and engagement, and reduction of certain pre-analytical errors, especially those related to specimen transportation. On the other hand, POCT also poses some limitations and risks, namely the risk of lower accuracy and reliability compared to traditional laboratory tests, quality control and connectivity issues, high dependence on operators (with varying levels of expertise or training), challenges related to patient data management, higher costs per individual test, regulatory and compliance issues such as the need for appropriate validation prior to clinical use (especially for rapid diagnostic tests; RDTs), as well as additional preanalytical sources of error that may remain undetected in this type of testing, which is usually based on whole blood samples (i.e., presence of interfering substances, clotting, hemolysis, etc.). There is no doubt that POCT is a breakthrough innovation in laboratory medicine, but the discussion on its appropriate use requires further debate and initiatives. This collective opinion paper, composed of abstracts of the lectures presented at the two-day expert meeting “Point-Of-Care-Testing: State of the Art and Perspective” (Venice, April 4–5, 2024), aims to provide a thoughtful overview of the state-of-the-art in POCT, its current applications, advantages and potential limitations, as well as some interesting reflections on the future perspectives of this particular field of laboratory medicine.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Point-of-care testing: state-of-the art and perspectives ; volume:63 ; number:1 ; year:2025 ; pages:35-51 ; extent:17
Clinical chemistry and laboratory medicine ; 63, Heft 1 (2025), 35-51 (gesamt 17)

Creator
Plebani, Mario
Nichols, James H.
Luppa, Peter B.
Greene, Dina
Sciacovelli, Laura
Shaw, Julie
Khan, Adil I.
Carraro, Paolo
Freckmann, Guido
Dimech, Wayne
Zaninotto, Martina
Spannagl, Michael
Huggett, Jim
Kost, Gerald J.
Trenti, Tommaso
Padoan, Andrea
Thomas, Annette
Banfi, Giuseppe
Lippi, Giuseppe

DOI
10.1515/cclm-2024-0675
URN
urn:nbn:de:101:1-2412011509347.227098112962
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Plebani, Mario
  • Nichols, James H.
  • Luppa, Peter B.
  • Greene, Dina
  • Sciacovelli, Laura
  • Shaw, Julie
  • Khan, Adil I.
  • Carraro, Paolo
  • Freckmann, Guido
  • Dimech, Wayne
  • Zaninotto, Martina
  • Spannagl, Michael
  • Huggett, Jim
  • Kost, Gerald J.
  • Trenti, Tommaso
  • Padoan, Andrea
  • Thomas, Annette
  • Banfi, Giuseppe
  • Lippi, Giuseppe

Other Objects (12)